XTalks
AUGUST 30, 2022
One of the biggest challenges with developing therapies to treat CNS disorders is the delivery of systemically administered investigational products (IPs) to the brain, which is limited by the blood-brain barrier. Some methods of direct CNS administration include intrathecal, intraparenchymal and intracerebroventricular (ICV) delivery.
Druggist
OCTOBER 21, 2020
It is recommended that a particular group of people; for example, diabetic patients seek advice from a podiatrist or diabetic nurse as any infections in diabetes may lead to complications. Novel Drug Delivery Strategies for the Treatment of Onychomycosis. J Am Board Fam Med. 2011 Jan-Feb;24(1):69-74. doi: 10.3122/jabfm.2011.01.100124.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 23, 2022
This challenging environment, in addition to the measures taken to restrict people’s movement in order to reduce the viruses spread, led to many of the vital clinical trials being carried out to shift towards decentralised trial procedures that utilised virtual medicine and direct-to-patient (DtP) drug delivery.
FDA Law Blog
JUNE 23, 2024
For example, intrathecal infusion therapy, via an implanted infusion pump, or Targeted Drug Delivery (TDD”), is a last-line therapy for patients who have failed all other conventional pain therapies. In either event, the 2016 DEA guidance letter is not currently published or otherwise available on DEA’s guidance portal. [4]
Expert insights. Personalized for you.
83 
Let's personalize your content